Cord blood soluble Fas ligand and pediatric atopic dermatitis

Allergy and Asthma Proceedings

Volumn 32, Issue 5, 2011, Pages 366-371

  Su, Kuan Wen ^a   Chen, Pau Chung ^b   Wang, I Jen ^a,c,d  

^a TAIPEI HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; IMMUNOGLOBULIN E;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MATERNAL BLOOD; TAIWAN; UMBILICAL CORD BLOOD;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FAS LIGAND PROTEIN; FEMALE; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN E; INFANT; INFANT, NEWBORN; QUESTIONNAIRES;

EID: 80053394373     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3468     Document Type: Article

References (30)

1. Williams H, and Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol 118:209 -213, 2006.
2. Stensen L, Thomsen SF, and Backer V. Change in prevalence of atopic dermatitis between 1986 and 2001 among children. Allergy Asthma Proc 29:392-396, 2008.
3. Kay J, Gawkrodger DJ, Mortimer MJ, et al. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 30:35-39, 1994. (Pubitemid 24033816)
4. Illi S, Von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 113:925-931, 2004. (Pubitemid 38608603)
5. Weidinger S, Illig T, Baurecht H, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118:214-219, 2006. (Pubitemid 43949588)
6. Simpson AB, Yousef E, and Hossain J. Evaluation of the relationship between IgE level and skin superinfection in children with atopic dermatitis. Allergy Asthma Proc 31:232-237.
7. Greenhawt M. The role of food allergy in atopic dermatitis. Allergy Asthma Proc 31:392-397.
8. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39:650-654, 2007. (Pubitemid 46676107)
9. Nagata S, and Golstein P. The Fas death factor. Science 267: 1449-1456, 1995.
10. Janssen O, Qian J, Linkermann A, et al. CD95 ligand-Death factor and costimulatory molecule? Cell Death Differ 10:1215-1225, 2003. (Pubitemid 37407124)
11. Vargo-Gogola T, Crawford HC, Fingleton B, et al. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 408: 155-161, 2002. (Pubitemid 36027034)
12. Holler N, Tardivel A, Kovacsovics-Bankowski M, et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol 23:1428 -1440, 2003.
13. Trautmann A, Akdis M, Kleemann D, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 106:25-35, 2000. (Pubitemid 30437237)
14. Sohn MH, Lee KE, and Kim KE. Interleukin-18 is associated with increased severity of atopic dermatitis in children. Allergy Asthma Proc 25:181-184, 2004.
15. Benn CS, Benfeldt E, Andersen PK, et al. Atopic dermatitis in young children: Diagnostic criteria for use in epidemiological studies based on telephone interviews. Acta Derm Venereol 83:347-350, 2003. (Pubitemid 37281541)
16. Chan HH, Pei A, van Krevel C, et al. Validation of the Chinese translated version of ISAAC core questions for atopic eczema. Clin Exp Allergy 31:903-907, 2001. (Pubitemid 34204263)
17. Yamada E, vanna AT, Naspitz CK, et al. International Study of Asthma and Allergies in Childhood (ISAAC): Validation of the written questionnaire (eczema component) and prevalence of atopic eczema among Brazilian children. J Investig Allergol Clin Immunol 12:34-41, 2002. (Pubitemid 34507064)
18. Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 124:1251-1258 e1223, 2009.
19. Sohn MH, Kim JW, Kim WK, et al. Staphylococcal enterotoxin B upregulates fas-mediated apoptosis of peripheral blood mono-nuclear cells in childhood atopic dermatitis. Scand J Immunol 57:62- 67, 2003.
20. Cork MJ, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene-environment interactions. J Allergy Clin Immunol 118:3-21, 2006. (Pubitemid 43946484)
21. Farley SM, Dotson AD, Purdy DE, et al. Fas ligand elicits a caspase-independent proinflammatory response in human keratinocytes: Implications for dermatitis. J Invest Dermatol 126: 2438-2451, 2006. (Pubitemid 44582266)
22. Ottonello L, Tortolina G, Amelotti M, et al. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J Immunol 162:3601-3606, 1999. (Pubitemid 29313614)
23. Ueta M, Sotozono C, Inatomi T, et al. Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome. Br J Ophthalmol 92:989 -991, 2008.
24. Zhang B, Sun T, Xue L, et al. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis 28:1067-1073, 2007. (Pubitemid 47072192)
25. Kavurma MM, and Khachigian LM. Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ 10:36-44, 2003. (Pubitemid 36511831)
26. Tenda Y, Yamashita M, Kimura MY, et al. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice. J Allergy Clin Immunol 118:725-733, 2006. (Pubitemid 44301400)
27. Devillers AC, van Toorenenbergen AW, Klein Heerenbrink GJ, et al. Elevated levels of plasma matrix metalloproteinase-9 in patients with atopic dermatitis: A pilot study. Clin Exp Dermatol 32:311-313, 2007. (Pubitemid 46495803)
28. Sarandakou A, Protonotariou E, Rizos D, et al. Soluble Fas antigen and soluble Fas ligand in early neonatal life. Early Hum Dev 75:1-7, 2003. (Pubitemid 37491051)
29. Hide DW, Arshad SH, Twiselton R, et al. Cord serum IgE: An insensitive method for prediction of atopy. Clin Exp Allergy 21:739 -743, 1991.
30. Edenharter G, Bergmann RL, Bergmann KE, et al. Cord blood-IgE as risk factor and predictor for atopic diseases. Clin Exp Allergy 28:671- 678, 1998.